Sanofi-Aventis (SNY) SWOT Analysis
Weaknesses
Opportunities
Threats
Sanofi-Aventis (SNY) SWOT Analysis Profile
Sanofi-aventis is a developer, manufacturer, and marketer of life-enhancing medicines, vaccines, pharmaceuticals, and integrated healthcare solutions worldwide. The companys brand names include Lovenox/Clexane, Plavix/Iscover, Stilnox/Ambien/Ambien CR/Myslee, Taxotere, Eloxatin, Lantus, Aprovel/Avapro/Karvea, Triatec/Tritace/Delix/Altace, Allegra/Telfast, Amaryl/Amarel/Solosa, Xatral, Actonel, Depakine, and Nasacort. (read full profile)
Additional Information
What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.
Receive News & Ratings Via Email
Free Email Newsletter
Popular SWOT Analyses
SWOT Conclusion
Strengths + Opportunities = 9
Threats + Weaknesses = 6
… A history of overcoming weaknesses makes it difficult for other firms to exploit their difficulties. A good defense against threats lowers the risks that profits will decrease.
SWOT Analysis Survey